Biosimilars and generics as "rip-offs": when the facts may not matter By Neil Wilkof at Friday, March 10, 2017 biosimilars Bloomberg confirmation bias Elisabeth Kolbert generics Gideon Parchomovsky Neil Wilkof Peter Siegelman Rashi +